Penn Medicine Provider
Cardiology
Roy Arjoon, MD
4.7
(298)
Accepting new patients
Sees patients age 18 and up
Penn Cardiology Penn Presbyterian
View 1 additional location

About me

  • Clinical Assistant Professor of Medicine (Cardiovascular Medicine)

Education and training

  • Medical School: Boston University School of Medicine
  • Residency: Boston Medical Center
  • Fellowship: Yale-New Haven Hospital

What my patients think about me

Average Rating
4.7

298 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
i like him
April 2025
5.0
5.0
very happy
April 2025
5.0
5.0
dr arjoon is very professional and displays confidence which made me feel confident in his diagnosis and treatment plan
April 2025
5.0
5.0
knowledge and patient centric responses

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Arjoon is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Karim S, Arjoon R, Rosenfeld L, Bhatt P Lyme Carditis Presenting as Sinus Node Dysfunction and Accelerated Junctional Rhythm. , Heart Rhythm Society Annual Meeting, San Francisco, CA: 2016


Arjoon R, Brogan A Unusual Consequences of an Intramuscular NSAID Injection: Streptococcus pneumoniae Subdeltoid Bursitis and Endocarditis. , American College of Physicians Internal Medicine Conference, Orlando, FL: 2014


Kiani S, Arjoon R, Flynn M, Kurian D, Henkin S, Steinwegner T, Desai PH, Poston RS Bleeding in patients undergoing minimally invasive robotic-assisted coronary artery bypass grafting with and without clopidogrel treatment: the experience of hybrid coronary revascularization. , Boston University Science and Engineering Day 2011, Boston, MA: 2011


Arjoon R, Kiani S, Flynn M, Kurian D, Henkin S, Steinwegner T, Desai PH, Poston RS Comparing outcomes in patients undergoing minimally invasive coronary artery bypass grafting before and after percutaneous coronary intervention: hybrid coronary revascularization as an answer to the increased bleeding potential of previously stented patients. , Massachusetts Medical Society’s Fifth Annual Research Poster Symposium, Waltham, MA: 2010


Shrikhande G, Scali S, Da Silva C, Damrauer S, Csizmadia E, Putheti P, Matthey M, Arjoon R, Patel R, Fisher M, Daniel S, Patel V, Siracuse J, Maccariello E, Monahan T, Andersen N, Kocher O, Veves A, Usheva A, Kaczmarek E, Ferran C O-Glycosylation Regulates Degradation of the Anti-Inflammatory and Atheroprotective Protein A20 to Accelerate Atherosclerosis in diabetic ApoE-null mice. , PLoS One, 5(12): 2010,e14240


Brown X, Arjoon R, Wong J Substrate Stiffness Modulates Vascular Smooth Muscle Cell Response to PDGF: Involvement of Lipid Rafts. , American Society of Cell Biology’s Annual Meeting, San Francisco, CA: 2006


Arjoon R, Brown X, Wong J Cell Signaling in Vascular Smooth Muscle Cells on Bioengineered Substrates. , Annual Beckman Scholars Symposium at University of California, Irvine: 2006